Detalhe da pesquisa
1.
Robust control for convection suppression in a fluid layer: The effects of boundary properties, actuator lag, and major parameter uncertainties.
Phys Rev E Stat Nonlin Soft Matter Phys
; 73(4 Pt 2): 046307, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16711929
2.
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
J Natl Cancer Inst
; 68(2): 227-31, 1982 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-6950156
3.
Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicin.
J Natl Cancer Inst
; 84(22): 1725-30, 1992 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-1433357
4.
Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
Cancer Res
; 43(7): 3417-21, 1983 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-6850648
5.
Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.
Cancer Res
; 51(14): 3643-7, 1991 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-2065322
6.
Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.
Cancer Res
; 40(3): 567-72, 1980 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-7471076
7.
Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.
Cancer Res
; 42(1): 354-8, 1982 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-7053862
8.
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.
Cancer Res
; 41(5): 1916-22, 1981 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-7214359
9.
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.
Cancer Res
; 48(9): 2574-8, 1988 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-3356017
10.
A reassessment of the role of second-look laparotomy in advanced ovarian cancer.
J Clin Oncol
; 5(9): 1316-21, 1987 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-3625253
11.
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.
J Clin Oncol
; 3(11): 1535-40, 1985 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-2997408
12.
Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
J Clin Oncol
; 14(7): 1993-9, 1996 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-8683229
13.
Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.
J Clin Oncol
; 12(3): 553-9, 1994 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-8120553
14.
Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.
J Clin Oncol
; 9(5): 809-17, 1991 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-2016624
15.
Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
J Clin Oncol
; 11(8): 1511-6, 1993 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8393096
16.
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
J Clin Oncol
; 10(1): 117-27, 1992 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-1727913
17.
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.
J Clin Oncol
; 17(8): 2553-61, 1999 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10561322
18.
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.
J Clin Oncol
; 17(3): 880-6, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10071279
19.
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.
J Clin Oncol
; 8(8): 1335-41, 1990 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-2199620
20.
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
J Clin Oncol
; 15(4): 1318-32, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9193323